Complementary medicine in Germany: a multi-centre cross-sectional survey on the usage by and the needs of patients hospitalized in university medical centers.


Journal

BMC complementary medicine and therapies
ISSN: 2662-7671
Titre abrégé: BMC Complement Med Ther
Pays: England
ID NLM: 101761232

Informations de publication

Date de publication:
23 Nov 2021
Historique:
received: 04 05 2021
accepted: 08 11 2021
entrez: 24 11 2021
pubmed: 25 11 2021
medline: 15 12 2021
Statut: epublish

Résumé

The results of recent surveys indicate that more than 50% of the German population has experience with complementary and alternative medicine (CAM) or uses CAM regularly. This study investigated the CAM usage and CAM-related needs of hospitalized patients at university medical centres in the state of Baden-Württemberg, Germany. A multi-centre, paper-based, pseudonymous survey was carried out by the members of the Academic Centre for Complementary and Integrative Medicine. Patients of all ages, regardless of sex, diagnosis and treatment, who were hospitalized in the Department of Cardiology, Gastroenterology, Oncology, Gynaecology or Surgery at the university medical centres in Freiburg, Heidelberg, Tübingen and Ulm were eligible for inclusion. Of the 1275 eligible patients, 67% (n = 854) consented to participate in the survey. Forty-eight percent of the study participants stated that they were currently using CAM. The most frequently used therapies were exercise (63%), herbal medicine (54%) and dietary supplements (53%). Only 16% of the patients discussed CAM usage with their attending physician. Half of the patients (48%) were interested in CAM consultations. More than 80% of the patients desired reliable CAM information and stated that physicians should be better informed about CAM. The frequency of CAM usage and the need for CAM counselling among hospitalized patients at university medical centres in Baden-Württemberg are high. To better meet patients' needs, CAM research and physician education should be intensified. German Clinical Trial register ( DRKS00015445 ).

Sections du résumé

BACKGROUND BACKGROUND
The results of recent surveys indicate that more than 50% of the German population has experience with complementary and alternative medicine (CAM) or uses CAM regularly. This study investigated the CAM usage and CAM-related needs of hospitalized patients at university medical centres in the state of Baden-Württemberg, Germany.
METHODS METHODS
A multi-centre, paper-based, pseudonymous survey was carried out by the members of the Academic Centre for Complementary and Integrative Medicine. Patients of all ages, regardless of sex, diagnosis and treatment, who were hospitalized in the Department of Cardiology, Gastroenterology, Oncology, Gynaecology or Surgery at the university medical centres in Freiburg, Heidelberg, Tübingen and Ulm were eligible for inclusion.
RESULTS RESULTS
Of the 1275 eligible patients, 67% (n = 854) consented to participate in the survey. Forty-eight percent of the study participants stated that they were currently using CAM. The most frequently used therapies were exercise (63%), herbal medicine (54%) and dietary supplements (53%). Only 16% of the patients discussed CAM usage with their attending physician. Half of the patients (48%) were interested in CAM consultations. More than 80% of the patients desired reliable CAM information and stated that physicians should be better informed about CAM.
CONCLUSIONS CONCLUSIONS
The frequency of CAM usage and the need for CAM counselling among hospitalized patients at university medical centres in Baden-Württemberg are high. To better meet patients' needs, CAM research and physician education should be intensified.
TRIAL REGISTRATION BACKGROUND
German Clinical Trial register ( DRKS00015445 ).

Identifiants

pubmed: 34814885
doi: 10.1186/s12906-021-03460-6
pii: 10.1186/s12906-021-03460-6
pmc: PMC8609851
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

285

Informations de copyright

© 2021. The Author(s).

Références

Phytother Res. 2019 Sep;33(9):2409-2420
pubmed: 31313391
Inflamm Bowel Dis. 2005 Mar;11(3):287-95
pubmed: 15735435
BMC Complement Altern Med. 2006 May 22;6:19
pubmed: 16716218
BMJ Open. 2012 Sep 03;2(5):
pubmed: 22945962
J Altern Complement Med. 2017 Apr;23(4):264-267
pubmed: 28304182
Can J Surg. 2009 Oct;52(5):422-6
pubmed: 19865579
Oncology. 2017;93(3):157-163
pubmed: 28641281
Am J Pharm Educ. 2008 Feb 15;72(1):11
pubmed: 18322573
BMC Complement Altern Med. 2018 Sep 24;18(1):259
pubmed: 30249217
Int J Clin Pharmacol Ther. 2002 Dec;40(12):539-47
pubmed: 12503811
Complement Ther Med. 2018 Dec;41:105-110
pubmed: 30477825
Orv Hetil. 2016 Sep;157(37):1483-8
pubmed: 27615199
BMJ Open. 2020 Sep 6;10(9):e037192
pubmed: 32895280
Int J Clin Pract. 2017 Jul;71(7):
pubmed: 28524414
Complement Ther Med. 2019 Jun;44:83-90
pubmed: 31126579
BMC Complement Altern Med. 2016 Nov 8;16(1):446
pubmed: 27825376
Scand J Public Health. 2018 Jun;46(4):448-455
pubmed: 28975853
Integr Cancer Ther. 2012 Sep;11(3):187-203
pubmed: 22019489
Altern Ther Health Med. 2004 Jan-Feb;10(1):32-6
pubmed: 14727497
Altern Ther Health Med. 2020 Sep;26(5):8-16
pubmed: 32663179
Forsch Komplementarmed Klass Naturheilkd. 2004 Aug;11(4):207-11
pubmed: 15347903
Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):e1-6
pubmed: 23040545
PLoS One. 2015 Oct 29;10(10):e0141985
pubmed: 26513370
Mult Scler. 2008 Sep;14(8):1113-9
pubmed: 18632773
Med Oncol. 2016 Jul;33(7):78
pubmed: 27300549

Auteurs

Ann-Kathrin Lederer (AK)

Center for Complementary Medicine, Department of Medicine II, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Theodor von Frerichs Haus, Sir-Hans-A.-Krebs-Straße, 79106, Freiburg, Germany.
Chirurgische Klinik, Evangelisches Diakoniekrankenhaus, Freiburg, Germany.

Alexandra Baginski (A)

Center for Complementary Medicine, Department of Medicine II, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Theodor von Frerichs Haus, Sir-Hans-A.-Krebs-Straße, 79106, Freiburg, Germany.

Lena Raab (L)

Center for Complementary Medicine, Department of Medicine II, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Theodor von Frerichs Haus, Sir-Hans-A.-Krebs-Straße, 79106, Freiburg, Germany.

Stefanie Joos (S)

Institute for General Practice and Interprofessional Care, University Hospital Tübingen, Tübingen, Germany.

Jan Valentini (J)

Institute for General Practice and Interprofessional Care, University Hospital Tübingen, Tübingen, Germany.

Carina Klocke (C)

Institute for General Practice and Interprofessional Care, University Hospital Tübingen, Tübingen, Germany.

Yvonne Samstag (Y)

Institute of Immunology, Section Molecular Immunology, University of Heidelberg, Heidelberg, Germany.

Katrin Hübner (K)

Institute of Immunology, Section Molecular Immunology, University of Heidelberg, Heidelberg, Germany.

Ivana Andreeva (I)

Institute of Immunology, Section Molecular Immunology, University of Heidelberg, Heidelberg, Germany.

Thomas Simmet (T)

Institute of Pharmacology of Natural Products & Clinical Pharmacology, Ulm University, Ulm, Germany.

Tatiana Syrovets (T)

Institute of Pharmacology of Natural Products & Clinical Pharmacology, Ulm University, Ulm, Germany.

Susanne Hafner (S)

Institute of Pharmacology of Natural Products & Clinical Pharmacology, Ulm University, Ulm, Germany.

Anna Freisinger (A)

Institute of Pharmacology of Natural Products & Clinical Pharmacology, Ulm University, Ulm, Germany.

Maximilian Andreas Storz (MA)

Center for Complementary Medicine, Department of Medicine II, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Theodor von Frerichs Haus, Sir-Hans-A.-Krebs-Straße, 79106, Freiburg, Germany.

Roman Huber (R)

Center for Complementary Medicine, Department of Medicine II, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Theodor von Frerichs Haus, Sir-Hans-A.-Krebs-Straße, 79106, Freiburg, Germany. roman.huber@uniklinik-freiburg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH